IRIS
CICCIA, Francesco
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 12.030
AS - Asia 6.640
NA - Nord America 4.529
SA - Sud America 1.486
AF - Africa 111
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 24.803
Salva come PNG Salva come JPEG
Nazione #
RU - Federazione Russa 8.965
US - Stati Uniti d'America 4.405
SG - Singapore 2.256
IE - Irlanda 1.306
CN - Cina 1.220
BR - Brasile 1.209
VN - Vietnam 1.173
HK - Hong Kong 1.078
IT - Italia 456
GB - Regno Unito 416
KR - Corea 346
DE - Germania 285
GR - Grecia 174
IN - India 169
AR - Argentina 110
FR - Francia 77
FI - Finlandia 61
JP - Giappone 61
BD - Bangladesh 54
ID - Indonesia 51
EC - Ecuador 49
CA - Canada 48
SE - Svezia 46
MX - Messico 44
UA - Ucraina 38
TR - Turchia 37
ZA - Sudafrica 34
AT - Austria 30
CO - Colombia 30
NL - Olanda 30
PL - Polonia 30
ES - Italia 28
IQ - Iraq 25
PK - Pakistan 24
PY - Paraguay 21
MA - Marocco 19
UZ - Uzbekistan 19
VE - Venezuela 19
BE - Belgio 18
PE - Perù 17
CH - Svizzera 15
EG - Egitto 15
TH - Thailandia 15
CL - Cile 12
CZ - Repubblica Ceca 12
KE - Kenya 12
DZ - Algeria 11
AE - Emirati Arabi Uniti 10
KZ - Kazakistan 10
SA - Arabia Saudita 10
JM - Giamaica 9
TW - Taiwan 9
UY - Uruguay 9
AZ - Azerbaigian 8
BO - Bolivia 8
PH - Filippine 8
JO - Giordania 7
MY - Malesia 7
NP - Nepal 7
RS - Serbia 7
OM - Oman 5
PA - Panama 5
TN - Tunisia 5
AL - Albania 4
GT - Guatemala 4
IL - Israele 4
MK - Macedonia 4
PT - Portogallo 4
AU - Australia 3
CI - Costa d'Avorio 3
CR - Costa Rica 3
GA - Gabon 3
GE - Georgia 3
HN - Honduras 3
HU - Ungheria 3
KG - Kirghizistan 3
LA - Repubblica Popolare Democratica del Laos 3
LK - Sri Lanka 3
MD - Moldavia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
XK - ???statistics.table.value.countryCode.XK??? 3
AM - Armenia 2
BG - Bulgaria 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
EE - Estonia 2
IR - Iran 2
LB - Libano 2
LT - Lituania 2
NG - Nigeria 2
NO - Norvegia 2
RO - Romania 2
SY - Repubblica araba siriana 2
TJ - Tagikistan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
Totale 24.787
Salva come PNG Salva come JPEG
Città #
Moscow 3.132
Dublin 1.305
Hong Kong 1.041
Santa Clara 1.027
Singapore 938
San Jose 464
Jacksonville 400
Ho Chi Minh City 394
Seoul 342
Hanoi 282
Hefei 257
Ashburn 241
Princeton 187
Roxbury 187
Beijing 179
Chandler 176
Medford 140
Bremen 121
Naples 92
Bengaluru 90
São Paulo 89
New York 79
Los Angeles 77
Da Nang 76
Des Moines 63
Dallas 62
Ann Arbor 51
Cambridge 50
Boardman 47
Munich 46
The Dalles 44
Council Bluffs 43
Haiphong 41
Wilmington 41
Jinan 37
Rome 37
Rio de Janeiro 35
Nanjing 30
Falkenstein 25
Nuremberg 25
Atlanta 24
Belo Horizonte 24
Biên Hòa 24
Curitiba 24
Guarulhos 23
Turku 23
Boston 21
Chennai 21
Hải Dương 21
Dearborn 20
Guayaquil 20
Tokyo 20
Brasília 19
Orem 19
Porto Alegre 19
Frankfurt am Main 18
Guangzhou 18
Bắc Ninh 17
Ninh Bình 17
Shanghai 17
Tashkent 17
Campinas 16
Hebei 16
Helsinki 16
Johannesburg 16
Lappeenranta 16
Warsaw 16
Amsterdam 15
Buenos Aires 15
Milan 15
Montreal 15
Shenyang 15
Brussels 14
Caserta 14
Houston 14
London 14
Vũng Tàu 14
Bangkok 13
Jakarta 13
Phủ Lý 13
Salvador 13
Vienna 13
Can Tho 12
Goiânia 12
Hillsboro 12
Mexico City 12
Palermo 12
San Francisco 12
Thái Bình 12
Bến Tre 11
Norwalk 11
Ribeirão Preto 11
Thái Nguyên 11
Tianjin 11
Brooklyn 10
Huế 10
Lima 10
Redwood City 10
São Gonçalo 10
São José dos Campos 10
Totale 12.924
Salva come PNG Salva come JPEG
Nome #
Ankylosing spondylitis: an autoimmune or autoinflammatory disease? 194
An intense physical rehabilitation programme determines pain relief and improves the global quality of life in patients with fibromyalgia 172
A 2-year comparative open label randomized study of efficacy and safety of etanercept and infliximab in patients with ankylosing spondylitis 166
Adult-onset Still's disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 151
Adult-onset Still's disease: Evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 150
ABERRANT EXPRESSION OF IL-22RA1 ON HEMATOPOIETIC CELLS AS IMMUNOLOGICALLY SIGNATURE OF PRIMARY SJOGREN’S SYNDROME AND SJOGREN-ASSOCIATED NON-HODGKIN LYMPHOMAS 143
CD3 immunohistochemistry is helpful in the diagnosis of giant cell arteritis 139
Fatigue and Associated Factors in an Immune-Mediated Inflammatory Disease Population: A Cross-Sectional Study 137
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 134
Adalimumab efficacy in enteropathic spondyloarthritis: A 12-mo observational multidisciplinary study 131
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 131
CD8+tissue-resident memory T cells are expanded in primary Sjögren’s disease and can be therapeutically targeted by CD103 blockade 129
An observational prospective study on predictors of clinical response at six months in patients with active psoriatic arthritis treated with golimumab 129
Anifrolumab in Refractory Systemic Lupus Erythematosus: A Real-World, Multicenter Study 128
Expression of HIF1α in intestinal epithelium restricts arthritis inflammation by inhibiting RIPK3-induced cell death machinery 127
Arterial stiffness indexes and serum cytokine levels in seronegative spondyloarthritis: relationships between stiffness markers and metabolic and immunoinflammatory variables 127
Durable renal response and safety with add-on belimumab in patients with lupus nephritis in real-life setting (BeRLiSS-LN). Results from a large, nationwide, multicentric cohort 127
Serological Response to BNT162b2 Anti-SARS-CoV-2 Vaccination in Patients with Inflammatory Rheumatic Diseases: Results From the RHEUVAX Cohort 126
Are Toll-like receptors and decoy receptors involved in the immunopathogenesis of systemic lupus erythematosus and lupus-like syndromes? 125
Anti-tumour necrosis factor alpha monoclonal antibody therapy for recalcitrant cerebral vasculitis in a patient with Behçet's syndrome 124
Gastrointestinal Symptoms Impact Psychosocial Function and Quality of Life in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Cross-Sectional Study 123
A Th1 but not a Th17 response is present in the gastrointestinal involvement of Behçet's disease 123
Anti-tumour necrosis factor monoclonal antibody treatment for ocular Behçet's disease 122
Influence of hydroxychloroquine blood levels on adhesion molecules associated with endothelial dysfunction in patients with systemic lupus erythematosus 121
Precision medicine in systemic lupus erythematosus 120
Clinical and subclinical atherosclerosis in patients with systemic sclerosis: an observational, multicentre study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) 118
Adult-onset Still's disease with elderly onset: results from a multicentre study 118
Satisfaction in Social Roles and Physical Function in Immune-mediated Inflammatory Diseases: A Cross-Sectional Study 117
Incidence of COVID-19 in an Italian cohort of patients with systemic lupus erythematosus: an observational survey 117
Clinical and laboratory features associated with macrophage activation syndrome in Still's disease: data from the international AIDA Network Still's Disease Registry 116
Early and Late Response and Glucocorticoid-Sparing Effect of Belimumab in Patients with Systemic Lupus Erythematosus with Joint and Skin Manifestations: Results from the Belimumab in Real Life Setting Study—Joint and Skin (BeRLiSS-JS) 116
Systemic sclerosis interstitial lung disease: unmet needs and potential solutions 116
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 116
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still's disease 116
IL-23 OVEREXPRESSION AS IMMUNOLOGICAL SIGNATURE OF SUBCLINICAL INTESTINAL INFLAMMATION IN PATIENTS WITH ANKYLOSING SPONDYLITIS 115
Safety and efficacy of secukinumab treatment in a patient with ankylosing spondylitis and concomitant multiple sclerosis 115
Biomarker panels may be superior over single molecules in prediction of renal flares in systemic lupus erythematosus: an exploratory study 115
A patient-driven registry on Behçet's disease: the AIDA for patients pilot project 114
ILC3 in Axial Spondyloarthritis: the Gut Angle 112
Distinctive gut microbiomes of ankylosing spondylitis and inflammatory bowel disease patients suggest differing roles in pathogenesis and correlate with disease activity 112
New insights into the pathogenesis of giant cell arteritis: are they relevant for precision medicine? 111
Gut dysbiosis in Spondyloarthritis: Cause or effect? 111
Butyrophilin 2a2 (Btn2a2) expression on thymic epithelial cells promotes central T cell tolerance and prevents autoimmune disease 110
H-ferritin and CD68+/H-ferritin+ monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 110
Activated IL-22 pathway occurs in the muscle tissues of patients with polymyositis or dermatomyositis and is correlated with disease activity 110
Gut epithelial impairment, microbial translocation and immune system activation in inflammatory bowel disease-Associated spondyloarthritis 109
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 108
Autophagy occurs in lymphocytes infiltrating Sjögren’s syndrome minor salivary glands and correlates with histological severity of salivary gland lesions 107
JAK/STAT Pathway Targeting in Primary Sjögren Syndrome 107
Tocilizumab therapy for unresponsive pulmonary arterial hypertension in a patient with Takayasu arteritis 106
NKP44+NK cells are expanded and produce high amounts of IL-22 in the salivary glands of Sjrogen syndrome patients 106
Macrophage Activation Syndrome in Patients Affected by Adult-onset Still Disease: Analysis of Survival Rates and Predictive Factors in the Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale Cohort 105
Systemic sclerosis-associated interstitial lung disease in the EUSTAR database: analysis by region 104
Clinical characteristics of obese patients with adult-onset Still's disease. Data from a large multicentre cohort 104
Early disease and low baseline damage predict response to belimumab in patients with systemic lupus erythematosus 104
Microbiome Changes in Connective Tissue Diseases and Vasculitis: Focus on Metabolism and Inflammation 103
Hydroxychloroquine daily dose, hydroxychloroquine blood levels and the risk of flares in patients with systemic lupus erythematosus 103
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 103
The gut-enthesis axis and the pathogenesis of Spondyloarthritis 102
Phenotype and functional changes of Vgamma9/Vdelta2 T lymphocytes in Behçet's disease and the effect of infliximab on Vgamma9/Vdelta2 T cell expansion, activation and cytotoxicity 102
Real-life efficacy of guselkumab in patients with early psoriatic arthritis 102
Correction to: Impact of smoking habit on adult-onset Still's disease prognosis, findings from a multicentre observational study 101
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 101
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management 101
Type 3 innate lymphoid cells producing IL-17 and IL-22 are expanded in the gut, in the peripheral blood, synovial fluid and bone marrow of patients with ankylosing spondylitis 101
Gut-derived CD8+ tissue-resident memory T cells are expanded in the peripheral blood and synovia of SpA patients 101
Intensive training programme for ultrasound-guided minimally invasive synovial tissue biopsy on knees and wrists in different phases of inflammation 100
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies very early cardiac involvement in systemic sclerosis patients of recent onset 100
JAK/STAT pathway and nociceptive cytokine signalling in rheumatoid arthritis and psoriatic arthritis 100
Short-Facelift Approach in Temporal Artery Biopsy: Is It Safe? 99
null 99
Interleukin-22 and interleukin-22-producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis 99
The craniovertebral junction in rheumatoid arthritis: State of the art 99
Chronic conventional disease-modifying anti-rheumatic drugs masking severe SARS-CoV-2 manifestations in an elderly rheumatic patient 99
Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database 98
Persistence of C-reactive protein increased levels and high disease activity are predictors of cardiovascular disease in patients with axial spondyloarthritis 98
Parenchymal lung disease in adult onset Still's disease: An emergent marker of disease severity - Characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients 98
Intestinal Involvement in Kawasaki Disease 97
Interstitial lung disease in systemic sclerosis: current and future treatment 97
Pathogenesis of primary Sjögren's syndrome beyond B lymphocytes 97
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 96
The Autoinflammatory Diseases Alliance Registry of monogenic autoinflammatory diseases 96
The Cross-Talk between Microbiome and Metabolome in Rheumatoid Arthritis 96
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 96
Gut inflammation in spondyloarthritis 96
Targeting zonulin and intestinal epithelial barrier function to prevent onset of arthritis 96
Impact of smoking habit on adult-onset Still’s disease prognosis, findings from a multicentre observational study 96
Efficacy and safety of tocilizumab in adult-onset Still's disease: Real-life experience from the international AIDA registry 95
IVIG in APS pregnancy 95
Non-conventional forms of HLA-B27 are expressed in spondyloarthritis joints and gut tissue 95
β-amyloid wall deposit of temporal artery in subjects with spontaneous intracerebral haemorrhage 95
Cardiovascular disease in primary sjögren’s syndrome 95
Systematic review and meta-analysis of cardiovascular risk in rheumatological disease: Symptomatic and non-symptomatic events in rheumatoid arthritis and systemic lupus erythematosus 95
Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6 94
Targeting IL-6 signalling in early rheumatoid arthritis is followed by Th1 and Th17 suppression and Th2 expansion 94
Inflammasome activation in Ankylosing Spondylitis is associated to gut dysbiosis 94
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 93
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS 93
Autophagy in the pathogenesis of ankylosing spondylitis 93
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 93
Totale 11.140
Salva come PNG Salva come JPEG
Categoria #
all - tutte 96.570
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 96.570
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 0 0 0 0 0 8
2021/20221.010 21 11 1 24 372 4 37 16 48 28 66 382
2022/20231.724 246 12 26 17 208 59 4 60 1.020 5 43 24
2023/20241.032 35 30 39 55 368 101 27 29 11 7 57 273
2024/20254.236 14 45 9 88 646 518 478 439 537 940 304 218
2025/202616.021 545 866 894 963 1.266 8.304 1.231 582 674 309 212 175
Totale 25.382